Acitretin (Mylan Pharmaceuticals Inc.)
Welcome to the PulseAid listing for the Acitretin drug offered from Mylan Pharmaceuticals Inc.. This Retinoid [EPC],Retinoids [Chemical/Ingredient] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
| LABELER NAME / MANUFACTURER: | Mylan Pharmaceuticals Inc. |
| NON-PROPRIETARY NAME: | acitretin |
| SUBSTANCE NAME: | ACITRETIN |
| TYPE: | HUMAN PRESCRIPTION DRUG |
| PHARMA CLASS: | Retinoid [EPC],Retinoids [Chemical/Ingredient] |
| ROUTE: | ORAL |
| DOSAGE FORM: | CAPSULE |
| MARKETING CATEGORY NAME: | ANDA |
| START MARKETING DATE: | 2016-03-10 |
| END MARKETING DATE: | 0000-00-00 |
Acitretin HUMAN PRESCRIPTION DRUG Details:
| Item Description | Acitretin from Mylan Pharmaceuticals Inc. |
| LABELER NAME: | Mylan Pharmaceuticals Inc. |
| DEA SCHEDULE: |
|
| ACTIVE STRENGTH: | 10(mg/1) |
| START MARKETING DATE: | 2016-03-10 |
| END MARKETING DATE: | 0000-00-00 |
| PRODUCT ID: | 0378-7020_5e79418b-d55f-473c-b8b7-afc59aa6772e |
| PRODUCT NDC: | 0378-7020 |
| APPLICATION NUMBER: | ANDA202148 |
Other ACITRETIN Pharmaceutical Manufacturers / Labelers:
